Novo Nordisk shares tumble 11% after company forecasts sales declines this year

The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key U.S. market....

By CNBC · CNBC

The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key U.S. market.